BRPI0507283A - compostos orgánicos - Google Patents

compostos orgánicos

Info

Publication number
BRPI0507283A
BRPI0507283A BRPI0507283-2A BRPI0507283A BRPI0507283A BR PI0507283 A BRPI0507283 A BR PI0507283A BR PI0507283 A BRPI0507283 A BR PI0507283A BR PI0507283 A BRPI0507283 A BR PI0507283A
Authority
BR
Brazil
Prior art keywords
compounds
organic compounds
ccr3
meanings
preparing
Prior art date
Application number
BRPI0507283-2A
Other languages
English (en)
Inventor
Gurdip Bhalay
Andrew Dunstan
Angela Glen
Trevor John Howe
Clive Mccarthy
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0507283A publication Critical patent/BRPI0507283A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Holo Graphy (AREA)

Abstract

COMPOSTOS ORGáNICOS. Composto de fórmula l em forma livre ou de sal, em que T, X, Y, U, R¬, R¬, m, n e p têm os significados indicados no relatório, são utilizáveis para tratamento de estados mediados por CCR3. Também são descritas composições farmacêuticas que contêm os compostos e processos para a preparação dos compostos.
BRPI0507283-2A 2004-01-30 2005-01-28 compostos orgánicos BRPI0507283A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402101.0A GB0402101D0 (en) 2004-01-30 2004-01-30 Organic compounds
PCT/EP2005/000874 WO2005075420A2 (en) 2004-01-30 2005-01-28 Pyrrolidine derivatives acting as ccr3-receptor antagonists

Publications (1)

Publication Number Publication Date
BRPI0507283A true BRPI0507283A (pt) 2007-07-03

Family

ID=31971770

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507283-2A BRPI0507283A (pt) 2004-01-30 2005-01-28 compostos orgánicos

Country Status (14)

Country Link
US (1) US7754758B2 (pt)
EP (1) EP1791815B1 (pt)
JP (1) JP2007519680A (pt)
KR (1) KR20060128971A (pt)
CN (1) CN1910145B (pt)
AT (1) ATE488497T1 (pt)
AU (1) AU2005211491B2 (pt)
BR (1) BRPI0507283A (pt)
CA (1) CA2552928A1 (pt)
DE (1) DE602005024828D1 (pt)
GB (1) GB0402101D0 (pt)
MX (1) MXPA06008572A (pt)
RU (1) RU2006131044A (pt)
WO (1) WO2005075420A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10544099B2 (en) * 2016-05-04 2020-01-28 Bristol-Myers Squibb Company Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine
US5274097A (en) * 1988-04-19 1993-12-28 Bayer Aktiengesellschaft 1,3-disubstituted pyrrolidines
US6605623B1 (en) * 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CO5300399A1 (es) * 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR028947A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
WO2001098269A2 (en) * 2000-06-21 2001-12-27 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
TW200305395A (en) 2002-03-15 2003-11-01 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CN1910145B (zh) 2010-06-16
EP1791815B1 (en) 2010-11-17
JP2007519680A (ja) 2007-07-19
MXPA06008572A (es) 2006-08-28
WO2005075420A3 (en) 2005-10-06
US7754758B2 (en) 2010-07-13
WO2005075420A2 (en) 2005-08-18
RU2006131044A (ru) 2008-03-10
AU2005211491B2 (en) 2008-09-11
AU2005211491A1 (en) 2005-08-18
EP1791815A2 (en) 2007-06-06
GB0402101D0 (en) 2004-03-03
CN1910145A (zh) 2007-02-07
US20090306138A1 (en) 2009-12-10
KR20060128971A (ko) 2006-12-14
DE602005024828D1 (de) 2010-12-30
ATE488497T1 (de) 2010-12-15
CA2552928A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
TW200617009A (en) Organic compounds
SV2010003463A (es) Compuestos organicos
BRPI0519292A2 (pt) compostos orgÂnicos
GB0305152D0 (en) Organic compounds
TW200519106A (en) Organic compounds
TW200635921A (en) Organic compounds
TN2010000167A1 (en) Organic compounds
NO20055688L (no) Organiske forbindelser
TW200732335A (en) Organic compounds
TW200517386A (en) Organic compounds
TW200628463A (en) Heteroaryl compounds
CY1112237T1 (el) Παραγωγα 5-υδροξυ-βενζοθειαζολης που εχουν ενεργοτητα αγωνιστη βητα-2-αδρενοϋποδοχεα
TW200745004A (en) Novel compounds, their preparation and use
EA200700286A1 (ru) Применение замещённых производных 2-пирролидона в качестве фунгицидов и инсектицидов
TW200732337A (en) Organic compounds
ATE541839T1 (de) Pyrrolidiniumderivate als m3-muskarinische rezeptoren
GB0508314D0 (en) Organic compounds
ATE449069T1 (de) Aminopropanolderivate
SE0401762D0 (sv) Novel compounds
CO5690637A2 (es) Tiazol-(bi) cicloalquil-carboxanilidas
MXPA05013823A (es) Derivados de pirrolidinio y piperidino como ligandos para el receptor m3 muscarinico.
WO2007068473A3 (en) Organic compounds
GB0602951D0 (en) Organic Compounds
ATE554774T1 (de) 2-methylen-19-nor-(20s-24epi)-1alpha,25- dihydrovitamin-d2
BRPI0507283A (pt) compostos orgánicos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]